Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US Congress Roundup: Senators Reject COVID-19 Relief Plan; Lawmakers Fault Verma Promos

House Energy and Commerce Committee also passes bill that increases oxygen equipment payments, as Congress gets back to work

Executive Summary

Upon US lawmakers’ return from an August recess, senators wrangle over an acceptable coronavirus relief package, while the House finalizes medtech bills and probes Medicare chief Seema Verma’s expenses.

You may also be interested in...



New Democratic Senate Poised To Approve More Generous COVID-19 Relief Bills, Biden Cabinet Chiefs

Elections guaranteeing a Democratic Senate mean President-Elect Joe Biden can push for $2,000 COVID-19 relief checks and get his Cabinet choices.

US Government Awards $481M To Help Cue Health Expand COVID-19 Test Production

Cue’s point-of-care molecular test earned an FDA emergency use authorization in June.

Bill Advances Mandating Private Insurance Coverage Of Devices To Correct Birth Defects

Proposed legislation that would require private insurers to cover devices to correct cleft palate, congenital cataracts and other birth defects advanced in the US House on 9 September.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT142727

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel